Purpose: e use of morning basal serum cortisol levels as an alternative to dynamic testing for assessment of hypothalamic-pituitary-adrenal (HPA) axis has previously been reported. e purpose of this study was to determine the lower and upper cuto values that would obviate subsequent HPA axis testing.Methods: A single-centre, retrospective study from a tertiary care endocrinology clinic was conducted, analyzing data from 106 adult individuals referred for HPA axis testing who had undergone a 0800-0900 morning basal serum cortisol test followed by a standard dose (250 μg) adrenocorticotropin (ACTH) stimulation test.e ability of morning basal serum cortisol values to predict post-ACTH 30 or 60 minute peak cortisol value of >500 or >550 nmol/L was investigated.Results: A morning basal cuto of <128 nmol/L is su cient for predicting a post-ACTH value < 550 nmol/L, and morning basal cuto levels of >243 nmol/L and >266 nmol/L predict peak post-ACTH values of >500 and >550 nmol/L respectively, obviating the need for dynamic testing. Regression analysis further demonstrated the log-linear relationship between morning basal and peak levels, while also nding a signi cant decrease in peak post-ACTH levels for patients diagnosed with secondary hypothyroidism (76 nmol/ L lower, p=0.003) or secondary hypogonadism (61 nmol/L lower, p=0.02). ese data suggest that the risk of cortisol de ciency is signi cantly higher in individuals with additional pituitary insu ciencies. e odds ratios for cortisol de ciency in patients with history of isolated secondary hypothyroidism was 3.41 (p=0.015), with isolated secondary hypogonadism was 4.77 (p=0.002) and with both was 7.45 (p=0.0002).
Conclusion:Morning basal serum cortisol levels show promise as an e ective screening test for HPA insu ciency for most patients. Clinicians should consider the high probability of HPA insu ciency in patients with one or more pituitary insu ciencies.